# OnCo record nct03790111 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03790111/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03790111", "NCT03790111" ;
  schema:name "A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer"@en ;
  schema:description "A phase 2 trial of Telotristat ethyl in Biliary tract cancer and Biliary tract cancer, run by TerSera Therapeutics LLC, recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct03790111/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03790111> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/biliary-tract-cancer/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:drugs <https://onco.cc/drugs/telotristat-ethyl/> ;
  onco:companies <https://onco.cc/companies/tersera-therapeutics/> .